封面
市场调查报告书
商品编码
1621613

动物疫苗市场:按动物类型、技术、给药途径、分销管道划分 - 全球预测 2025-2030

Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年动物疫苗市值为98.2亿美元,预计2024年将达104亿美元,复合年增长率为6.43%,预计2030年将达到151.9亿美元。

动物疫苗市场包括开发和生产专为动物设计的疫苗,以预防疾病、促进健康并提高牲畜和伴同性动物的生产力。这些疫苗对于预防通用感染疾病的爆发、降低动物死亡率和最大限度地减少农业部门的经济损失至关重要。其用途范围从牛、家禽等牲畜到宠物。这个多元化的市场主要是由动物保健支出增加、牲畜数量增加以及对动物性食品的需求增加等因素所推动的。此外,宠物拥有量的增加也推动了对伴同性动物疫苗的需求。关键的成长要素包括推动新疫苗开发的生物技术进步以及支持动物健康的政府措施。在亚太和非洲等尚未开发的地区,畜牧业产量正在迅速增长,因此存在扩大服务的潜在机会。您可以透过与当地兽医院合作并探索适合您需求的疫苗接种策略来进一步提高市场渗透率。然而,疫苗储存和运输成本高、监管障碍以及牲畜所有者对疫苗犹豫不决等挑战正在限製成长。此外,人们普遍缺乏对动物健康实践的认识,特别是在开发中地区。在技​​术创新方面,开发频谱且提供持久免疫力的疫苗可能会改变游戏规则。 DNA 疫苗和重组疫苗等生物技术创新是利润丰厚的研发领域。儘管成长轨迹充满希望,但市场竞争仍较为激烈,知名公司大力投资研发併购,以扩大其产品线和市场。透过策略教育措施和加强分销网络来解决限制对于永续成长至关重要。公司应注重监管合规性,以避免潜在的陷阱,并支持提高对动物健康和疫苗接种益处的认识的努力。

主要市场统计
基准年[2023] 98.2亿美元
预计年份 [2024] 104亿美元
预测年份 [2030] 151.9亿美元
复合年增长率(%) 6.43%

市场动态:揭示快速发展的兽用疫苗市场的关键市场洞察

供需的动态交互作用正在改变动物疫苗市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 饲养的伴同性动物和牲畜数量增加
    • 动物慢性病和意外伤害发生率增加
    • 政府针对兽医动物疫苗接种的倡议
  • 市场限制因素
    • 疫苗开发、储存和处理相关的高成本
  • 市场机会
    • 从减毒活病毒疫苗到 DNA 疫苗的过渡
    • 加大投资和研发力度,开发新型动物疫苗
  • 市场挑战
    • 对严格监管合规的担忧

波特五力:驾驭动物疫苗市场的策略工具

波特的五力框架是了解兽用疫苗市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解兽用疫苗市场的外部影响

外部宏观环境因素对兽用疫苗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。

市场占有率分析 了解动物疫苗市场竞争状况

对兽用疫苗市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵兽用疫苗市场供应商的绩效评估

FPNV定位矩阵是评估兽用疫苗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议,规划兽用疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说,对动物疫苗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开发:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 饲养宠物和牲畜的数量增加
      • 动物慢性病和意外伤害发生率增加
      • 政府关于兽医动物疫苗接种的倡议
    • 抑制因素
      • 疫苗开发、储存和处理相关的高成本
    • 机会
      • 从减毒活疫苗到 DNA 疫苗的转变
      • 加大兽用疫苗新开发研发投入
    • 任务
      • 对严格监管合规的担忧
  • 市场区隔分析
    • 动物类型:增加使用疫苗预防牲畜疾病
    • 技术:增加灭活感测器的使用,减轻狂犬病、流感、钩端螺旋体病等针对性疾病的负担
    • 给药途径:鼻内给药由于其易于使用和非侵入性而越来越受到青睐。
    • 分销管道:提高兽医院和诊所的疫苗供应
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章动物疫苗市场:依动物类型

  • 水产养殖
  • 伴同性动物
  • 家畜
    • 猪肉
    • 家禽
    • 小反刍动物

第七章动物疫苗市场:依技术分类

  • 灭活疫苗
  • 减毒活疫苗
  • 重组疫苗
  • 类毒素疫苗

第八章动物疫苗市场:依给药途径分类

  • 静脉
  • 鼻腔
  • 口服

第九章动物疫苗市场:依通路划分

  • 医院/诊所
  • 零售药房

第十章美洲动物疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太动物疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲动物疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • 默克动物保健推出 3 剂猪疫苗
    • IIL投资70亿印度卢比在印度海得拉巴建立新的动物疫苗部门
    • 默克动物保健公司收购 Benk
  • 战略分析和建议

公司名单

  • Addison Biological Laboratory Inc.
  • Aptimmune Biologics, Inc
  • Bimeda Inc.
  • Biokema SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • Endovac Animal Health.
  • Hester Biosciences Limited
  • HIPRA, SA
  • Indian Immunologicals Ltd.
  • Kemin Industries, Inc.
  • Kyoritsuseiyaku Corporation
  • Laboratoire LCV
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Saiba Animal Health AG
  • Sumitomo Pharma Animal Health Co., Ltd.
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova International BV
  • Virbac SA
  • YEBIO BIOENGINEERING CO., LTD OF QINGDAO
  • Zoetis Inc.
Product Code: MRR-4316E4E89380

The Veterinary Vaccines Market was valued at USD 9.82 billion in 2023, expected to reach USD 10.40 billion in 2024, and is projected to grow at a CAGR of 6.43%, to USD 15.19 billion by 2030.

The veterinary vaccines market encompasses the development and production of vaccines tailored for animals to prevent diseases, enhance health, and improve productivity across livestock and companion animals. These vaccines are essential for preventing outbreaks of zoonotic diseases, reducing animal mortality, and minimizing economic losses in the agricultural sector. Their application covers livestock, such as cattle and poultry, and extends to pets. This diverse market is primarily driven by factors like rising animal healthcare expenditure, an increase in livestock population, and growing demand for animal-derived food products. Additionally, the increased pet adoption rates fuel the demand for companion animal vaccines. Key growth influencers include advancements in biotechnology, which have propelled the development of novel vaccines, and governmental initiatives supporting animal health. Potential opportunities lie in expanding services in under-researched regions like Asia-Pacific and Africa, where livestock farming is burgeoning. Exploring partnerships with local veterinary clinics for tailored vaccination strategies can further enhance market penetration. However, challenges such as high costs of vaccine storage and transportation, regulatory hurdles, and vaccine hesitancy among livestock owners limit growth. Additionally, there's a widespread lack of awareness regarding animal health practices, particularly in developing regions. In terms of innovation, developing vaccines with broad-spectrum capabilities and those offering long-lasting immunity can be game-changing. Biotechnology innovations such as DNA and recombinant vaccines present lucrative R&D areas. Despite the promising growth trajectory, the market shows moderate competitive intensity with notable players investing heavily in R&D and mergers/acquisitions to augment product lines and market reach. Addressing limitations via strategic educational initiatives and enhancing distribution networks are pivotal for sustained growth. Businesses should focus on regulatory compliance to avoid potential pitfalls and support efforts to improve awareness about animal health and vaccination benefits.

KEY MARKET STATISTICS
Base Year [2023] USD 9.82 billion
Estimated Year [2024] USD 10.40 billion
Forecast Year [2030] USD 15.19 billion
CAGR (%) 6.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Vaccines Market

The Veterinary Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Rising incidence of chronic diseases and accidental injuries in animals
    • Government initiatives for immunization of veterinary animals
  • Market Restraints
    • High cost associated with development, storage, and handling of vaccines
  • Market Opportunities
    • Shift from live attenuated vaccines to DNA vaccines
    • Rising investments and R&D for development of novel veterinary vaccines
  • Market Challenges
    • Concerns associated with stringent regulatory compliance

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Vaccines Market

A detailed market share analysis in the Veterinary Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Vaccines Market

A strategic analysis of the Veterinary Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Animal Type, market is studied across Aquaculture, Companion Animals, and Livestock. The Livestock is further studied across Bovine, Porcine, Poultry, and Small Ruminants.
  • Based on Technology, market is studied across Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines.
  • Based on Route of Administration, market is studied across Intravenous, Nasal, and Oral.
  • Based on Distribution Channel, market is studied across Hospitals & Clinics and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Rising incidence of chronic diseases and accidental injuries in animals
      • 5.1.1.3. Government initiatives for immunization of veterinary animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with development, storage, and handling of vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
      • 5.1.3.2. Rising investments and R&D for development of novel veterinary vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with stringent regulatory compliance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Animal Type: Rising usage of vaccines for disease prevention in livestock animals
    • 5.2.2. Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
    • 5.2.3. Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
    • 5.2.4. Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Vaccines Market, by Animal Type

  • 6.1. Introduction
  • 6.2. Aquaculture
  • 6.3. Companion Animals
  • 6.4. Livestock
    • 6.4.1. Bovine
    • 6.4.2. Porcine
    • 6.4.3. Poultry
    • 6.4.4. Small Ruminants

7. Veterinary Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. Inactivated Vaccines
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant Vaccines
  • 7.5. Toxoid Vaccines

8. Veterinary Vaccines Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Nasal
  • 8.4. Oral

9. Veterinary Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Retail Pharmacies

10. Americas Veterinary Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Merck Animal Health launches 3-in-one swine vaccine
    • 13.3.2. IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
    • 13.3.3. Merck Animal Health to Acquire Venc
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addison Biological Laboratory Inc.
  • 2. Aptimmune Biologics, Inc
  • 3. Bimeda Inc.
  • 4. Biokema SA
  • 5. Boehringer Ingelheim International GmbH
  • 6. Brilliant Bio Pharma Private Limited
  • 7. Ceva Sante Animale
  • 8. China Animal Husbandry Industry Co., Ltd
  • 9. Covetrus, Inc.
  • 10. Elanco Animal Health Incorporated
  • 11. Endovac Animal Health.
  • 12. Hester Biosciences Limited
  • 13. HIPRA, S.A
  • 14. Indian Immunologicals Ltd.
  • 15. Kemin Industries, Inc.
  • 16. Kyoritsuseiyaku Corporation
  • 17. Laboratoire LCV
  • 18. Meiji Holdings Co., Ltd.
  • 19. Merck & Co., Inc
  • 20. Neogen Corporation
  • 21. Norbrook Laboratories Limited
  • 22. Phibro Animal Health Corporation
  • 23. Saiba Animal Health AG
  • 24. Sumitomo Pharma Animal Health Co., Ltd.
  • 25. Torigen Pharmaceuticals Inc.
  • 26. Vaxxinova International BV
  • 27. Virbac SA
  • 28. YEBIO BIOENGINEERING CO., LTD OF QINGDAO
  • 29. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2023